Kangmei Pharma | 600518 - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.01M 175K 2026-03
Avita Medical AUD 28.02M 1.55M 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Genomma Lab Internacional MXN 3.32B 99.85M 2026-03
Hypermarcas BRL 1.59B 36.2M 2025-12
Ionis Pharmaceuticals USD 364M 54M 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
Jiangsu Hengrui CNY 5.52B 604.29M 2026-03
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Moderna USD 1.78B 242M 2026-03
Organon & Co USD 903M 387M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Sh Fosun Pharma CNY 9.18B 2.12B 2026-03
Tectonic Therapeutic USD 21.52M 374K 2025-12
Viatris USD 3.54B 323.9M 2026-03
Wuxi Apptec CNY 7.33B 511.69M 2026-03
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03